As of Mar 24
| +0.06 / +1.03%|
The 1 analysts offering 12-month price forecasts for MediciNova Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +87.39% increase from the last price of 5.87.
The current consensus among 1 polled investment analysts is to Buy stock in MediciNova Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.